Skip to main content

Table 2 Laboratory Data

From: A multicenter cohort study of primary hypertension in Korea: study design and interim analysis of the Korean registry of target organ damage in hypertension (KorHR)

 

Overall (N = 1,318)

Incident (N = 611)

On treatment (N = 707)

Hemoglobin (g/dL)

14.6 ± 3.5

14.9 ± 1.6

14.4 ± 4.6

Hematocrit (%)

43.0 ± 4.5

44.0 ± 4.8

42.1 ± 3.9

Glucose (mg/dL)

108 ± 25

106 ± 24

109 ± 26

Impaired fasting glucose (%)

59.8

56.0

63.0

Total cholesterol (mg/dL)

188 ± 36

200 ± 36

177 ± 32

Triglyceride (mg/dL)

151 ± 109

166 ± 128

139 ± 87

HDL (mg/dL)

52 ± 14

51 ± 15

52 ± 13

LDL (mg/dL)

114 ± 33

127 ± 32

104 ± 31

Uric acid (mg/dL)

5.5 ± 2.4

5.8 ± 3.2

5.3 ± 1.4

Estimated GFR (mL/min/1.73 m2)

89 ± 20

93 ± 26

87 ± 21

Urine albumin creatinine ratio (mg/g), median (1/4 quartile, 3/4 quartile)

10.3 (4.9, 24.8)

10.5 (5.0, 23.7)

10.1 (4.8, 25.5)

Renin (ng/ml/h)

3.35 ± 6.75

3.12 ± 6.76

4.16 ± 6.71

Aldosterone (pg/mL)

9.8 ± 7.5

9.6 ± 6.5

10.42 ± 10.05

PWVa

1558 ± 285

1569 ± 289

1543 ± 278

Central SBP

133 ± 20

136 ± 19

130 ± 21

Central DBP

88 ± 13

92 ± 12

83 ± 12

Augmentation index

38 ± 27

33 ± 24

47 ± 28

  1. a PWV pulsed wave velocity